Citadel Advisors’s PACS Group PACS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.47M Sell
45,800
-56,800
-55% -$2.09M ﹤0.01% 6755
2025
Q4
$3.94M Buy
102,600
+70,100
+216% +$1.54M ﹤0.01% 4685
2025
Q3
$446K Sell
32,500
-22,000
-40% -$258K ﹤0.01% 9420
2025
Q2
$704K Sell
54,500
-477,500
-90% -$4.96M ﹤0.01% 7825
2025
Q1
$5.98M Buy
532,000
+499,100
+1,517% +$6.55M ﹤0.01% 3602
2024
Q4
$431K Buy
32,900
+27,600
+521% +$708K ﹤0.01% 8890
2024
Q3
$212K Sell
5,300
-600
-10% -$21.8K ﹤0.01% 10024
2024
Q2
$174K Buy
+5,900
New +$161K ﹤0.01% 10133

Other funds holding PACS

Citadel Advisors's PACS Position: Q1 2026 in Review

Citadel Advisors increased its PACS Group (PACS) stake by 37% in Q1 2026, buying an estimated $6.11M and bringing the position to 614,814 shares worth $19.7M. The position accounts for ﹤0.01% of the portfolio, ranked #2360.

Citadel Advisors first reported a position in PACS in Q2 2024 and has held it in 8 quarters since. The position peaked at $25.2M in Q2 2024. 215 funds tracked by Wall St. Rank hold PACS as of Q1 2026.

  • Citadel Advisors held 614,814 shares of PACS Group worth $19.7M as of Q1 2026.
  • Citadel Advisors bought 166,114 PACS Group shares in Q1 2026, an estimated $6.11M.
  • PACS Group made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #2360 holding.
  • Citadel Advisors first reported a position in PACS Group in Q2 2024 and has held it in 8 quarters since.
  • Citadel Advisors's PACS Group position peaked at $25.2M in Q2 2024.
  • 215 funds tracked by Wall St. Rank held PACS Group as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.